BRK-B vs SBET
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
SBET exhibits critical financial instability, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental weakness. While the company shows explosive year-over-year revenue growth of 1816%, this has not translated into profitability, as evidenced by a catastrophic operating margin of -4657.07% and consistent, massive earnings misses. The extreme disconnect between the 'Strong Buy' analyst consensus and the actual financial health suggests a speculative bubble or misplaced optimism. With a 5-year price decline of 99.1% and bearish insider activity, the company appears to be in a high-risk state of distress.
Compare Another Pair
Related Comparisons
BRK-B vs SBET: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Sharplink, Inc. (SBET) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.